Thermo Fisher Scientific Inc.
TMO · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $6,338,000 | $5,995,000 | $6,960,000 | $7,728,000 |
| Dep. & Amort. | $3,108,000 | $3,406,000 | $3,381,000 | $2,592,000 |
| Deferred Tax | -$1,209,000 | -$1,300,000 | -$995,000 | -$406,000 |
| Stock-Based Comp. | $301,000 | $278,000 | $307,000 | $230,000 |
| Change in WC | -$334,000 | -$537,000 | -$1,049,000 | -$1,558,000 |
| Other Non-Cash | $463,000 | $564,000 | $550,000 | $957,000 |
| Operating Cash Flow | $8,667,000 | $8,406,000 | $9,154,000 | $9,543,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,400,000 | -$1,479,000 | -$2,243,000 | -$2,523,000 |
| Net Acquisitions | -$3,132,000 | -$3,660,000 | -$39,000 | -$19,395,000 |
| Inv. Purchases | -$3,396,000 | $0 | -$15,000 | -$8,000 |
| Inv. Sales/Matur. | $1,770,000 | $70,000 | $15,000 | $8,000 |
| Other Inv. Act. | $317,000 | -$73,000 | $123,000 | -$14,000 |
| Investing Cash Flow | -$5,841,000 | -$5,142,000 | -$2,159,000 | -$21,932,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$2,403,000 | -$155,000 | $654,000 | $8,911,000 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$4,000,000 | -$3,000,000 | -$3,000,000 | -$2,000,000 |
| Dividends Paid | -$583,000 | -$523,000 | -$455,000 | -$395,000 |
| Other Fin. Act. | $194,000 | $56,000 | -$9,000 | $65,000 |
| Financing Cash Flow | -$6,792,000 | -$3,622,000 | -$2,810,000 | $6,581,000 |
| Forex Effect | -$91,000 | -$82,000 | -$139,000 | -$37,000 |
| Net Chg. in Cash | -$4,057,000 | -$440,000 | $4,046,000 | -$5,845,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,097,000 | $8,537,000 | $4,491,000 | $10,336,000 |
| End Cash | $4,040,000 | $8,097,000 | $8,537,000 | $4,491,000 |
| Free Cash Flow | $7,267,000 | $6,927,000 | $6,911,000 | $7,020,000 |